Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies

Susan C Brown1, Silvia Torelli, Martin Brockington

  • 1Dubowitz Neuromuscular Unit, Department of Paediatrics, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom. s.brown@ic.ac.uk

Insights

Mutations in the fukutin related protein (FKRP) gene are linked to congenital muscular dystrophy type 1C (MDC1C) and limb girdle muscular dystrophy type 2I (LGMD2I). Reduced alpha-dystroglycan expression correlates with disease severity in these muscular dystrophy subtypes.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Mutations in the fukutin related protein (FKRP) gene cause congenital muscular dystrophy type 1C (MDC1C) and limb girdle muscular dystrophy type 2I (LGMD2I).
  • Patients with these disorders often exhibit reduced alpha-dystroglycan expression on their sarcolemma.

Purpose of the Study:

  • To investigate the correlation between residual alpha-dystroglycan expression and clinical phenotype in FKRP-related muscular dystrophies.
  • To further elucidate the role of dystroglycan in the pathogenesis of MDC1C and LGMD2I.

Main Methods:

  • Immunocytochemical analysis of alpha-dystroglycan expression.
  • Genotyping of FKRP mutations in patients with MDC1C and LGMD2I.
  • Correlation of genotype with clinical severity and alpha-dystroglycan levels.

Main Results:

  • Three distinct categories of alpha-dystroglycan reduction were identified, correlating with clinical phenotypes.
  • Severe MDC1C cases showed profound alpha-dystroglycan depletion.
  • Moderate reduction was observed in Duchenne-like LGMD, often associated with a common FKRP mutation (C826A) and other mutations.
  • Milder LGMD2I cases, frequently homozygous for the Leu276Ile FKRP mutation, displayed subtle alpha-dystroglycan alterations.

Conclusions:

  • A clear correlation exists between FKRP genotype, alpha-dystroglycan expression levels, and the clinical phenotype in MDC1C and LGMD2I.
  • These findings support the central role of dystroglycan in the pathogenesis of these muscular dystrophies.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...